£6.5M
The financing round was led by Ornament Health with participation from Latécoere and LG Capital.
Caeli Nova
Caeli Nova develops advanced emergency oxygen systems for commercial aircraft and clinical settings.
£6.5MTotal raised
Caeli Nova develops breathing technology operating at the intersection of aviation and healthcare. The team of specialists is based across offices in the UK and Switzerland.
Categories
Team
TW
Tim Wakeford
CEO